Bioxytran (BIXT) Current Assets (2010 - 2026)
Bioxytran (BIXT) recorded Current Assets of $177,384 in Q2 2026, compared with $3,144 a year earlier and down 61.7% from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Bioxytran reported Current Assets of $513,465.
- Annual Current Assets has a five-year compound annual growth rate of 10.2% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $5,154 in FY2024 (-80.2%), $26,086 in FY2023 (-91.2%), $295,401 in FY2022 (+308.2%) and $72,358 in FY2021 (-77.1%).
- Quarterly Current Assets has ranged from $3,144 in Q2 2025 to $743,294 in Q3 2021 over the past five years.
- Peak year-over-year performance for Current Assets in the last five years was growth of 308.2% in Q4 2022, against a decline of 93.5% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $463,047 (Q1 2026), $513,465 (Q4 2025) and $14,499 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | 177,384.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 177,384.00 |
| Mar 31, 2026 | 463,047.00 |
| Dec 31, 2025 | 513,465.00 |
| Sep 30, 2025 | 14,499.00 |
| Jun 30, 2025 | 3,144.00 |
| Mar 31, 2025 | 4,348.00 |
| Dec 31, 2024 | 5,154.00 |
| Sep 30, 2024 | 34,672.00 |
| Jun 30, 2024 | 13,522.00 |
| Mar 31, 2024 | 10,024.00 |
| Dec 31, 2023 | 26,086.00 |
| Sep 30, 2023 | 80,273.00 |
| Jun 30, 2023 | 45,181.00 |
| Mar 31, 2023 | 153,801.00 |
| Dec 31, 2022 | 295,401.00 |
| Sep 30, 2022 | 374,190.00 |
| Jun 30, 2022 | 500,677.00 |
| Mar 31, 2022 | 739,584.00 |
| Dec 31, 2021 | 72,358.00 |
| Sep 30, 2021 | 743,294.00 |
API Access
Bioxytran Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();